2.50
price down icon2.72%   -0.07
after-market アフターアワーズ: 2.50
loading
前日終値:
$2.57
開ける:
$2.57
24時間の取引高:
23,478
Relative Volume:
0.01
時価総額:
$6.64M
収益:
$556.00K
当期純損益:
$-5.28M
株価収益率:
-1.1682
EPS:
-2.14
ネットキャッシュフロー:
$-6.23M
1週間 パフォーマンス:
-11.35%
1か月 パフォーマンス:
-6.37%
6か月 パフォーマンス:
-3.47%
1年 パフォーマンス:
-21.88%
1日の値動き範囲:
Value
$2.4377
$2.57
1週間の範囲:
Value
$2.4377
$2.92
52週間の値動き範囲:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
名前
Cyclerion Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
617-621-7722
Name
住所
301 BINNEY STREET, CAMBRIDGE, MA
Name
職員
0
Name
Twitter
@Cyclerion
Name
次回の収益日
2024-12-15
Name
最新のSEC提出書
Name
CYCN's Discussions on Twitter

CYCN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
2.50 6.64M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-10-20 開始されました Truist Buy
2021-09-24 開始されました Cantor Fitzgerald Overweight
2019-06-03 開始されました Credit Suisse Neutral

Cyclerion Therapeutics Inc (CYCN) 最新ニュース

pulisher
Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025
pulisher
Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025
pulisher
Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025
pulisher
Feb 05, 2025

Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics announces mixed shelf offering - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

3 Penny Stocks to Watch Now, 2/4/25 - TipRanks

Feb 04, 2025
pulisher
Feb 03, 2025

A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

Analyzing CYCN’s current quarter earnings projections - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 03, 2025
pulisher
Feb 01, 2025

Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn

Feb 01, 2025
pulisher
Jan 31, 2025

Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 31, 2025

Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 08, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Shares Up 3.5% – Time to Buy? - Defense World

Jan 08, 2025
pulisher
Jan 03, 2025

Looking Into Cyclerion Therapeutics's Recent Short Interest - Benzinga

Jan 03, 2025
pulisher
Dec 23, 2024

Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress - Stocks Telegraph

Dec 23, 2024
pulisher
Dec 19, 2024

Cyclerion Therapeutics (NASDAQ: CYCN) Amends License Agreement with Akebia Therapeutics and Generates Revenues for GrowthOn December 17, 2024, Cyclerion Therapeutics, Inc. filed an 8-K SEC Filing which detailed significant developments in its b - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Cyclerion advances growth strategy with new agreements - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion Therapeutics Secures Funding and Expands CNS Focus - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion advances growth strategy with new agreements By Investing.com - Investing.com UK

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewswire

Dec 17, 2024

Cyclerion Therapeutics Inc (CYCN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):